Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)

Fig. 3

Change in left ventricular mass index (LVMI). a Absolute change from baselinea in LVMI in patients with data available after 1, 2 or 3 years of treatment with idursulfase. b Percentage change from baseline in LVMI in patients with data available after 1, 2 or 3 years of treatment with idursulfase. Box plots illustrate the 25th, 50th (median) and 75th percentiles (boxes) and the 10th and 90th percentiles (whiskers). aThe baseline measurement was defined as the last recorded measurement in the 12 months preceding the start of idursulfase treatment. A post-baseline measurement was defined as the value recorded closest to the 1st, 2nd or 3rd anniversary of the baseline measurement, within 6 months either side of the anniversary date. If there were two values within equal times of the evaluation visit, the first value was used

Back to article page